- Home
- NAUT
as 05-30-2025 4:00pm EST
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 86.4M | IPO Year: | N/A |
| Target Price: | $3.58 | AVG Volume (30 days): | 176.1K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.66 - $3.09 | Next Earning Date: | 04-29-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Nautilus Biotechnolgy Inc. (NAUT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mallick Parag | NAUT | Chief Scientist | May 8 '25 | Buy | $0.73 | 13,500 | $9,885.15 | 20,491,892 | |
| Patel Sujal M | NAUT | CEO, President, and Secretary | Mar 19 '25 | Buy | $1.00 | 77,233 | $76,918.09 | 10,117,788 |
Latest Nautilus Biotechnolgy Inc. News
NAUT Breaking Stock News: Dive into NAUT Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Simply Wall St.
17 days ago
Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential
GuruFocus.com
a month ago
Nautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions ...
GlobeNewswire
a month ago
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
GlobeNewswire
2 months ago
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
Simply Wall St.
2 months ago
We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate
GuruFocus.com
3 months ago
Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ...
GlobeNewswire
3 months ago
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Compare NAUT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NAUT Nautilus Biotechnolgy Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.